eMedicine Specialties > Ophthalmology > Lid

Chalazion

Author: Izak F Wessels, MB, BCh, MMed, FRCSE, FRCO, BSc, FACS, Associate Professor, Department of Ophthalmology, Chattanooga Unit, University of Tennessee College of Medicine; Private Practice in Comprehensive and Surgical Ophthalmology, Allied Eye Associates
Contributor Information and Disclosures

Updated: Aug 3, 2007

Introduction

Background

A chalazion (Greek for hailstone) is a lipogranuloma of either a meibomian gland or a Zeis gland. When the former is involved, the lid nodule is characteristically hard and painless lid nodule; with the latter, it is marginal or superficial.

Pathophysiology

Lipid breakdown products, possibly from bacterial enzymes (as free fatty acids) or from retained sebaceous secretions, leak into the surrounding tissue and incite a granulomatous inflammatory response. The resulting mass of granulation tissue and chronic inflammation (with lymphocytes and lipid-laden macrophages) distinguishes a chalazion from an internal or external hordeolum, which is primarily an acute pyogenic inflammation with polymorphonuclear leucocytes and necrosis with pustule formation. However, one condition can result in the other because of their close proximity.

On clinical examination, the single, nontender, firm nodule (or, in rare cases, multiple nodules) is located deep within the lid or the tarsal plate, whereas a hordeolum is more superficial and is typically centered on an eyelash. Eversion of the lid may reveal the dilated meibomian gland and chronic inspissation of adjoining glands. With judicious pressure on the lid, the thick secretions can be seen extruding like toothpaste, resulting in tear debris.

Frequency

United States

Chalazia are common, but the exact incidence or prevalence is unknown.

International

No data about the prevalence or incidence are available.

Mortality/Morbidity

Acute inflammatory exacerbation can result in a rupture anteriorly (through the skin) or posteriorly (through the conjunctiva), forming a granuloma pyogenicum.

Race

No information about prevalence or incidence with respect to race is available.

Sex

  • Male and females seem equally affected, but precise information about prevalence and incidence is not available.
  • Contrary to popular opinion, research has not shown that the use of eyelid cosmetic products either causes or aggravates the condition.

Age

Chalazia occur in all age groups.

  • Chalazia are more common in adults than in children, as androgenic hormones increase sebum viscosity.
  • Although they are uncommon at extremes of age, pediatric cases may be encountered.
  • Hormonal influences on sebaceous secretion and viscosity may explain clustering at the time of puberty and during pregnancy. However, the large number of patients without evidence of hormonal alteration suggests that other mechanisms also apply.

Clinical

History

Patients usually present with a short history of recent lid discomfort, followed by acute inflammation (eg, redness, tenderness, swelling). They frequently have a long history of previous similar occurrences, because chalazia tend to recur in predisposed individuals.

Physical

Chalazia are more common on the upper lid than on the lower lid because of the increased number and length of meibomian glands present on the upper lid.

Chronic inspissation of the meibomian secretions may be apparent as meibomian gland dysfunction. This condition is characterized by pressure on the eyelids that produces copious toothpaste-like secretions instead of the normal small amount of clear, oily secretion. Sebaceous dysfunction and obstruction elsewhere (eg, comedones, oily face) are the only associated features or specific general findings.

Rosacea is a frequent associated finding.  When present, rosacea demonstrates very specific findings, such as facial erythema; telangiectatic and spider nevi on the malar, nasal, and lid skin; and rhinophyma.

Causes

Chalazia may arise spontaneously due to blockage of a gland orifice or due to an internal hordeolum. Chalazia are associated with seborrhea, chronic blepharitis, and acne rosacea.

Poor lid hygiene is occasionally associated with chalazia, although its causal role needs to be established. Although stress is often apparently associated with chalazia, it has not been proven as a cause, and the mechanism by which stress acts is unknown.

More on Chalazion

Overview: Chalazion
Differential Diagnoses & Workup: Chalazion
Treatment & Medication: Chalazion
Follow-up: Chalazion
References

References

  1. Ben Simon GJ, Huang L, Nakra T, Schwarcz RM, McCann JD, Goldberg RA. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective?. Ophthalmology. May 2005;112(5):913-7. [Medline].

  2. Gershen HJ. Chalazion. In: Master Techniques in Ophthalmic Surgery. Baltimore: Williams and Wilkins; 1995:370-3.

  3. Mansour AM, Chan CC, Crawford MA, Tabbarah ZA, Shen D, Haddad WF, et al. Virus-induced chalazion. Eye. Feb 2006;20(2):242-6. [Medline].

  4. Ozdal PC, Codere F, Callejo S, Caissie AL, Burnier MN. Accuracy of the clinical diagnosis of chalazion. Eye. Feb 2004;18(2):135-8. [Medline].

  5. Rosas Vasquez E, Campos Maocias P, Ocha Tirado JG. Chloracne in the 1990s. Int J Dermatol. 1966;35:643-645.

  6. Shiramizu KM, Kreiger AE, McCannel CA. Severe visual loss caused by ocular perforation during chalazion removal. Am J Ophthalmol. Jan 2004;137(1):204-5. [Medline].

  7. Soil DB, Wisnlow R. Surgery of the eyelids. In: Tasman W, Jaeger EA, eds. Duane's Foundations of Clinical Ophthalmology. Vol 5. JBL; 1999:56-9.

  8. Wessels IF. Chalazion. In: Fraunfelder FT, Roy FH, eds. Current Ocular Therapy. Philadelphia: W. B. Saunders; 2000:423-5.

  9. Wessels IF, Wessels GF. Lidocaine-prilocaine cream for local-anesthesia chalazion incision in children. Ophthalmic Surg Lasers. Jun 1996;27(6):431-3. [Medline].

Further Reading

Keywords

chalazia, hailstone, lipogranuloma, meibomian gland, Zeis gland, seborrhea, chronic blepharitis, acne rosacea, lid nodule, interior (posterior) hordeolum

Contributor Information and Disclosures

Author

Izak F Wessels, MB, BCh, MMed, FRCSE, FRCO, BSc, FACS, Associate Professor, Department of Ophthalmology, Chattanooga Unit, University of Tennessee College of Medicine; Private Practice in Comprehensive and Surgical Ophthalmology, Allied Eye Associates
Izak F Wessels, MB, BCh, MMed, FRCSE, FRCO, BSc, FACS is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Medical Editor

Jorge G Camara, MD, Chairman, Department of Ophthalmology and Otorhinolaryngology, Director of Fellowship Training Program, St Francis Medical Center; Associate Professor, Department of Surgery, University of Hawaii School of Medicine
Jorge G Camara, MD is a member of the following medical societies: American Academy of Ophthalmology and American Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Mark T Duffy, MD, PhD, Consulting Staff, Division of Oculoplastic, Orbito-facial, Lacrimal, and Reconstructive Surgery, Green Bay Eye Clinic, BayCare Clinic
Mark T Duffy, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Ophthalmic Plastic and Reconstructive Surgery, Sigma Xi, and Society for Neuroscience
Disclosure: Allergan - Botox Cosmetic Consulting fee Consulting; Quest medical - lacrimal balloons Honoraria Speaking and teaching

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.